Archive for Evommune

Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update

December 11, 2025

Inflammation biotech Evommune heads to NYSE with $150M IPO

November 10, 2025

Evommune nabs $150M in IPO amid federal shutdown

November 10, 2025

EQT-Backed Biotech Firm Evommune Raises $150 Million in IPO

November 10, 2025

Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

November 10, 2025

Inflammation biotech Evommune prices IPO after MapLight’s $250M debut

October 31, 2025